FAB — Fusion Antibodies Share News
0.000.00%
- £13.64m
- £13.30m
- £1.97m
REG - Fusion Antibodies - Half-year Financial Report
AnnouncementREG - Fusion Antibodies - Notice of Results
AnnouncementRCS - Fusion Antibodies - OptiMAL Library video
AnnouncementREG - Fusion Antibodies - OptiMAL® R&D Update
AnnouncementREG - Fusion Antibodies - Holding(s) in Company
AnnouncementREG - Fusion Antibodies - Result of AGM
AnnouncementREG - Fusion Antibodies - AGM statement and H1 trading update
AnnouncementREG - Fusion Antibodies - Contract win
AnnouncementREG - Fusion Antibodies - Posting of Annual Report & Notice of AGM
AnnouncementREG - Fusion Antibodies - OptiMAL R&D Update
AnnouncementRCS - Fusion Antibodies - Belfast investor presentation
AnnouncementREG - Fusion Antibodies - Final Results
AnnouncementREG - Fusion Antibodies - Contract Win
AnnouncementREG - Fusion Antibodies - Contract wins with existing client
AnnouncementRCS - Fusion Antibodies - Investor presentations
AnnouncementREG - Fusion Antibodies - Grant of U.S. Patent for OptiMAL
AnnouncementREG - Fusion Antibodies - Issue Notification: US Patent Update
AnnouncementREG - Fusion Antibodies - Director/PDMR Shareholding
AnnouncementREG - Fusion Antibodies - Total Voting Rights
Announcement